Logo image
Back
Temporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia
Journal article   Open access   Peer reviewed

Temporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia

Shakeel Mowlaboccus, Timothy T Perkins, Helen Smith, Theo Sloots, Sarah Tozer, Lydia-Jessica Prempeh, Chin Yen Tay, Fanny Peters, David Speers, Anthony D Keil, …
PloS one, Vol.11(6), e0158315
2016
DOI: https://doi.org/10.1371/journal.pone.0158315
PMCID: PMC4927168
PMID: 27355628
pdf
Published2.12 MBDownloadView
CC BY V4.0,  Open Access

Abstract

Adolescent Adult Aged Antigens, Bacterial - genetics Antigens, Bacterial - immunology Child Child, Preschool Genetic Drift Genome, Bacterial Humans Infant Infant, Newborn Likelihood Functions Meningococcal Infections - epidemiology Meningococcal Infections - prevention & control Meningococcal Vaccines - immunology Meningococcal Vaccines - therapeutic use Middle Aged Neisseria meningitidis, Serogroup B - genetics Serogroup Western Australia Young Adult
Neisseria meningitidis is the causative agent of invasive meningococcal disease (IMD). The BEXSERO® vaccine which is used to prevent serogroup B disease is composed of four sub-capsular protein antigens supplemented with an outer membrane vesicle. Since the sub-capsular protein antigens are variably expressed and antigenically variable amongst meningococcal isolates, vaccine coverage can be estimated by the meningococcal antigen typing system (MATS) which measures the propensity of the strain to be killed by vaccinated sera. Whole genome sequencing (WGS) which identifies the alleles of the antigens that may be recognised by the antibody response could represent, in future, an alternative estimate of coverage. In this study, WGS of 278 meningococcal isolates responsible for 62% of IMD in Western Australia from 2000-2014 were analysed for association of genetic lineage (sequence type [ST], clonal complex [cc]) with BEXSERO® antigen sequence type (BAST) and MATS to predict the annual vaccine coverage. A hyper-endemic period of IMD between 2000-05 was caused by cc41/44 with the major sequence type of ST-146 which was not predicted by MATS or BAST to be covered by the vaccine. An increase in serogroup diversity was observed between 2010-14 with the emergence of cc11 serogroup W in the adolescent population and cc23 serogroup Y in the elderly. BASTs were statistically associated with clonal complex although individual antigens underwent antigenic drift from the major type. BAST and MATS predicted an annual range of 44-91% vaccine coverage. Periods of low vaccine coverage in years post-2005 were not a result of the resurgence of cc41/44:ST-146 but were characterised by increased diversity of clonal complexes expressing BASTs which were not predicted by MATS to be covered by the vaccine. The driving force behind the diversity of the clonal complex and BAST during these periods of low vaccine coverage is unknown, but could be due to immune selection and inter-strain competition with carriage of non-disease causing meningococci.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

2 File views/ downloads
12 Record Views
23 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.23 Antibiotics & Antimicrobials
1.23.714 Neisseria/Haemophilus
Web Of Science research areas
Immunology
ESI research areas
Immunology
Logo image